FILE:BAX/BAX-8K-20041021131434.txt.gz
EVENTS:	Results of Operations and Financial Condition
TEXT:
ITEM: Results of Operations and Financial Condition
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
This Form 8-K/A is being filed solely to correct a typographical error in the schedule to the company's press release dated October 21, 2004 entitled "Key Product Line SalesUS/International" which is on page 13 of Exhibit 99. The corrected schedule is filed with this Form 8-K/A, and indicates that the growth rate in the U.S. for Bioscience-Other was negative 47% for the third quarter of 2004, as compared to the third quarter of 2003 (not positive 47%).
:
EXPLANATORY NOTE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Date: October 21, 2004
 

BAXTERPAGE 13
 
 
 
: In August 2004, the company restated its previously issued financial statements for 2001 through 2003 and the first quarter of 2004. This information reflects the restatements. Refer to the company's Form 10-K/A for the year ended December 31, 2003 and Forms 10-Q/A for the quarters ended March 31, 2004 and September 30, 2003 for further information.
Note


